Missing cancer gene explains why some lung tumors respond well to immunotherapy

Missing cancer gene explains why some lung tumors respond well to immunotherapy

For some patients with the most common type of lung cancer, known as lung adenocarcinoma, there's new hope. In a new study published in Cell Reports, Mayo Clinic researchers have found several previously unknown genetic and cellular processes that occur in lung adenocarcinoma tumors that respond well to immunotherapy.